ICS 2020 Scientific Podium Short Oral Session S17

Speakers
	Scientific Podium Short Oral Session S17
	Lunch provided
	On-Demand
J John PFA Heesakkers ICS Chair V Victor William Nitti ICS Chair
Professional interest
Urology

#229 OnabotulinumtoxinA versus IncobotulinumtoxinA in the treatment of idiopathic and neurogenic detrusor overactivity

Presenter: Antonella Giannantoni

Gubbiotti M¹, Rubilotta E², Balzarro M², Bini V³, Giannantoni A⁴
1. San Donato Hospital, Dept. of Urology, Arezzo; Serafico Institute, Research Center "InVita", Assisi, Italy, 2. AOUI Verona, Dept. of Urology, University of Verona, 3. University of Perugia, Dept. of Medicine, Perugia, Italy, 4. University of Siena, Dept. of Medical and Surgical Sciences and Neurosciences, Functional and Surgical Urology Unit, Siena, Italy
Detrusor Overactivity, Quality of Life (QoL), Incontinence

#230 THE RELATIONSHIP BETWEEN LOWER URINARY TRACTFUNCTION AND 123I- IOFLUPANE SCINTIGRAPHYIN PARKINSON’S DISEASE IN EARLY STAGE.scintigraphy in Parkinson’s disease.

Presenter: Fuyuki Tateno

Tateno F¹, Sakakibara R¹, Aiba Y¹, Ogata T¹, Takahashi O¹
1. Neurology Division, Department of Internal Medicine, Sakura Medical Center, Toho University
Overactive Bladder, Imaging, Incontinence, Urgency/Frequency

#231 Concomitant Retropubic Midurethral Sling and OnabotulinumtoxinA Injections Are a Safe Treatment Option for Mixed Urinary Incontinence

Presenter: Alix Komar

Komar A¹, Bretschneider C¹, Mueller M¹, Lewicky-Gaupp C¹, Collins S¹, Geynisman-Tan J¹, Tavathia M¹, Kenton K¹
1. Northwestern University
Mixed Urinary Incontinence, Female, Clinical Trial

#232 Attrition rates and predictors of long-term (> 5 year) continuation treatment with onabotulinumtoxinA intradetrusor injections

Presenter: Ramy Goueli

Goueli R¹, Hong J¹, Rodriguez D¹, Lemack G¹
1. University of Texas Southwestern Medical Center
Detrusor Overactivity, Neuropathies: Central, Urgency Urinary Incontinence, Overactive Bladder, Spinal Cord Injury

#233 Efficacy and Safety of Alternative OnabotulinumtoxinA Injection Paradigm for Overactive Bladder: Final Double Blind and Open Label Results

Presenter: David Glazier

Glazier D¹, Kennelly M², MacDiarmid S³, McCammon K⁴, Shapiro A⁵, McCrery R⁶, Boroujerdi A⁷, Bai Z⁷, Gao G⁷, Patel A⁷
1. Virginia Urology, 2. Atrium Health, 3. Alliance Urology Specialists, 4. Urology of Virginia, 5. Chesapeake Urology, 6. Adult Pediatric Urology & Urogynecology, PC, 7. Allergan plc
Clinical Trial, Neuromodulation, Incontinence, Overactive Bladder, Pharmacology

#234 Reduction in Incontinence Product Use and Associated Cost Savings After OnabotulinumtoxinA Treatment in Patients With Overactive Bladder

Presenter: Heinrich Schulte-Baukloh

Schulte-Baukloh H¹, Farrelly E², Lorenzo-Gómez M³, Boroujerdi A⁴, Hamid R⁵
1. Urologic practice, Charité University Hospital, Berlin, 2. Södersjukhuset Stockholm South General Hospital, 3. University of Salamanca, 4. Allergan plc, 5. University College London Hospitals
Incontinence, Overactive Bladder, Prospective Study

#235 Real World Outcomes of Intravesical Onabotulinum Toxin A in Patients with Symptomatic Overactive Bladder

Presenter: Gemma Scrimgeour

Scrimgeour G¹, Aleksejeva K¹, Axell R¹, Yasmin H¹, Nadeem M¹, Pakzad M¹, Hamid R¹, Ockrim J¹, Greenwell T¹
1. Department of Female, Functional and Restorative Urology, University College London Hospital, UK
Overactive Bladder, Urgency Urinary Incontinence, Detrusor Overactivity, Outcomes Research Methods, Retrospective Study

#236 The efficacy of onabotulinum toxin A in patients with previous failed augmentation cystoplasty

Presenter: Bogdan Toia

Toia B¹, Pakzad M¹, Hamid R¹, Wood D¹, Greenwell T¹, Ockrim J¹
1. UCLH
Surgery, Urgency/Frequency, Urgency Urinary Incontinence, Overactive Bladder

#237 Post Void Residual Volume and Rates of Clean Intermittent Catheterization With Spontaneous and Non-spontaneous Voiding After OnabotulinumtoxinA Treatment: Pooled Analysis of Two Phase 3 Studies

Presenter: Michael Kennelly

Kennelly M¹, Nitti V², Khullar V³, Herschorn S⁴, Karram M⁵, Boroujerdi A⁶, Patel A⁶
1. Atrium Health, 2. UCLA Geffen School of Medicine, 3. St. Mary's Hospital, Imperial College London, 4. University of Toronto, 5. The Christ Hospital, 6. Allergan plc
Urgency/Frequency, Urodynamics Techniques, Overactive Bladder

#238 Results after Onabotulinumtoxin A injection in patients with detrusor overactivity after stress urinary incontinence surgery

Presenter: Laura Mateu

Mateu L¹, Mayordomo O¹, Gutierrez C¹, Martínez V¹, Palou J¹, Errando C¹
1. Fundacio Puigvert
Overactive Bladder, Surgery, Mixed Urinary Incontinence

#239 Altered white matter integrity in patients with overactive bladder

Presenter: Ulrich Mehnert

Michels L¹, Stämpfli P², Leitner L³, Walter M³, Freund P⁴, Liechti M³, Luechinger R⁵, Kollias S⁶, Kessler T³, Mehnert U³
1. Department of Neuroradiology, University Hospital Zürich, Univerity of Zürich, 2. MR Center, Psychiatric University Hospital, University of Zürich, 3. Department of Neuro-Urology, Balgrist University Hospital, Univerity of Zürich, 4. Spinal Cord Injury Center, Balgrist University Hospital, Univerity of Zürich, 5. Institute for Biomedical Engineering, Swiss Federal Institute of Technology and University of Zürich, 6. Department of Neuroradiology, University Hospital Zürich, , Univerity of Zürich
Overactive Bladder, Female, Imaging, Prospective Study, Urgency/Frequency

#240 A NOVEL METHOD TO EVALUATE NEUROEXCITATION CHANGES IN RESPONSE TO AUDIO-VISUAL URGENCY TRIGGERS USING FUNCTIONAL NEAR-INFRARED SPECTROSCOPY (fNIRS)

Presenter: Natalie Swavely

Swavely N¹, Li R², Sivagnanalingam U¹, Koirala P¹, Maddra K¹, Egenberger K¹, Roberts S¹, Cullingsworth Z², Weprin S¹, Macnab A³, Stothers L³, Klausner A¹, Speich J²
1. Virginia Commonwealth University, Department of Surgery/Division of Urology, 2. Virginia Commonwealth University, Department of Mechanical & Nuclear Engineering, 3. University of British Columbia, Department of Urologic Sciences
Overactive Bladder, Imaging, Urgency Urinary Incontinence

Content Visitors (staff only)

International Continence Society

OAB: Neurotoxin and Imaging

Session Schedule

International Continence Society

OAB: Neurotoxin and Imaging

Session Schedule

Comments

Chat